A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)
Clinical trial NCT02775435 · COMPLETED
Trial details
- NCT number
- NCT02775435
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-09
- Primary completion
- 2018-04-03
- Enrollment
- 559
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.